PKA C alpha Antibody (6D2.1) [Janelia Fluor® 585]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-62195JF585
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Janelia Fluor 585
Antibody Source
Monoclonal Mouse IgG1 Clone # 6D2.1
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Peptide corresponding to amino acids ESPAQNTAHLDQFERIK of human proteinkinase A c alpha (PKAc alpha).
Specificity
The antibody C-50 reacts with Cytokeratin peptides 5 and 18 (58 and 45 kDa). Cytokeratins are a member of intermediate filaments subfamily represented in epithelial tissues.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for PKA C alpha Antibody (6D2.1) [Janelia Fluor® 585]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PKA C alpha
Long Name
cAMP-dependent Protein Kinase Catalytic Subunit alpha
Alternate Names
Cs, Pkaca, PKCA1, PKCD, PRKACA
Gene Symbol
PRKACA
Additional PKA C alpha Products
Product Documents for PKA C alpha Antibody (6D2.1) [Janelia Fluor® 585]
Product Specific Notices for PKA C alpha Antibody (6D2.1) [Janelia Fluor® 585]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...